Tag
Prices for brand-name and generic drugs in 2022 were nearly three times higher in the U.S. than in comparable countries.
On the one-year anniversary of the Inflation Reduction Act, CMS is poised to begin negotiating prices for the 10 most…
Last year, the makers of seven widely used prescription drugs raised prices substantially without any new clinical evidence to justify…
The U.S. Supreme Court recently agreed to hear a case that pits two groups on opposite sides of the debate…
One question Julie Appleby posed to a panel she moderated on the high cost of prescription drugs was simple enough:…
One of the best sessions at Health Journalism 2019 in Baltimore was the panel discussion about drug prices on May…
Drug prices have become a hot topic – and a significant source of the ongoing challenges to achieving affordable premiums…